 |
Indiana Administrative Code (Last Updated: December 20, 2016) |
 |
Title 410. INDIANA STATE DEPARTMENT OF HEALTH |
|
|
Article 410IAC1. COMMUNICABLE DISEASE CONTROL |
|
|
Rule 410IAC1-2.5. Disease Reporting and Control |
| Section 410IAC1-2.5-1. Applicability |
| Section 410IAC1-2.5-2. "Active surveillance" defined |
| Section 410IAC1-2.5-3. "Airborne precautions" defined |
| Section 410IAC1-2.5-4. "Approval" defined |
| Section 410IAC1-2.5-5. "Bloodborne pathogens" defined |
| Section 410IAC1-2.5-6. "Blood center" defined |
| Section 410IAC1-2.5-7. "Carrier" defined |
| Section 410IAC1-2.5-8. "Case" defined |
| Section 410IAC1-2.5-9. "Case ascertainment" defined |
| Section 410IAC1-2.5-10. "Case management" defined |
| Section 410IAC1-2.5-11. "Child" defined |
| Section 410IAC1-2.5-12. "Cleaning" defined |
| Section 410IAC1-2.5-13. "Commissioner" defined |
| Section 410IAC1-2.5-14. "Communicable disease" defined |
| Section 410IAC1-2.5-15. "Concurrent disinfection" defined |
| Section 410IAC1-2.5-16. "Confirmed foodborne disease outbreak" defined |
| Section 410IAC1-2.5-17. "Contact" defined |
| Section 410IAC1-2.5-18. "Contact precautions" defined |
| Section 410IAC1-2.5-19. "Contamination" defined |
| Section 410IAC1-2.5-20. "Control measures" defined |
| Section 410IAC1-2.5-21. "Counseling and testing site" defined |
| Section 410IAC1-2.5-22. "Daycare facility" defined |
| Section 410IAC1-2.5-23. "Daycare worker" defined |
| Section 410IAC1-2.5-24. "Department" defined |
| Section 410IAC1-2.5-25. "Directly observed therapy" or "DOT" defined |
| Section 410IAC1-2.5-26. "Disease intervention specialist" or "DIS" defined |
| Section 410IAC1-2.5-27. "Disinfect" defined |
| Section 410IAC1-2.5-28. "Droplet precautions" defined |
| Section 410IAC1-2.5-29. "Expedited partner therapy" or "EPT" defined |
| Section 410IAC1-2.5-30. "Food employee" defined |
| Section 410IAC1-2.5-31. "Food establishment" defined |
| Section 410IAC1-2.5-32. "Hand washing procedures" defined |
| Section 410IAC1-2.5-33. "HAV" defined |
| Section 410IAC1-2.5-34. "HBV" defined |
| Section 410IAC1-2.5-35. "HCV" defined |
| Section 410IAC1-2.5-36. "Health care facility" defined |
| Section 410IAC1-2.5-37. "Health care worker" defined |
| Section 410IAC1-2.5-38. "Health practitioner" defined |
| Section 410IAC1-2.5-39. "HEV" defined |
| Section 410IAC1-2.5-40. "Highly susceptible population" defined |
| Section 410IAC1-2.5-41. "HIV" defined |
| Section 410IAC1-2.5-42. "HIV infection/disease" defined |
| Section 410IAC1-2.5-43. "Infant" defined |
| Section 410IAC1-2.5-44. "Influenza-associated death" defined |
| Section 410IAC1-2.5-45. "Interferon gamma release assay" or "IGRA" defined |
| Section 410IAC1-2.5-46. "Invasive disease" defined |
| Section 410IAC1-2.5-47. "Isolation" defined |
| Section 410IAC1-2.5-48. "Latent tuberculosis infection" or "LTBI" defined |
| Section 410IAC1-2.5-49. "Local health officer" defined |
| Section 410IAC1-2.5-50. "Mantoux tuberculin skin test" or "TST" defined |
| Section 410IAC1-2.5-51. "Medical laboratory" defined |
| Section 410IAC1-2.5-52. "Multiple drug-resistant tuberculosis" or "MDR tuberculosis" defined |
| Section 410IAC1-2.5-53. "Other potentially infectious materials" defined |
| Section 410IAC1-2.5-54. "Outbreak" defined |
| Section 410IAC1-2.5-55. "Partner services" defined |
| Section 410IAC1-2.5-56. "Person in charge" defined |
| Section 410IAC1-2.5-57. "Postsecondary facility" defined |
| Section 410IAC1-2.5-58. "Preschool" defined |
| Section 410IAC1-2.5-59. "Prophylaxis" defined |
| Section 410IAC1-2.5-60. "Quarantine" defined |
| Section 410IAC1-2.5-61. "Ready-to-eat food" defined |
| Section 410IAC1-2.5-62. "Regulatory authority" defined |
| Section 410IAC1-2.5-63. "Residential institution" defined |
| Section 410IAC1-2.5-64. "Restrict" defined |
| Section 410IAC1-2.5-65. "Restriction of activities" defined |
| Section 410IAC1-2.5-66. "Sexually transmitted disease" defined |
| Section 410IAC1-2.5-67. "Standard precautions" defined |
| Section 410IAC1-2.5-68. "State designated districts" defined |
| Section 410IAC1-2.5-69. "Sterile site" defined |
| Section 410IAC1-2.5-70. "Sterilize" defined |
| Section 410IAC1-2.5-71. "Suspect case" defined |
| Section 410IAC1-2.5-72. "Terminal cleaning" defined |
| Section 410IAC1-2.5-73. "Tuberculosis disease" defined |
| Section 410IAC1-2.5-74. "Universal precautions" defined |
| Section 410IAC1-2.5-75. Reporting requirements for physicians and hospital administrators |
| Section 410IAC1-2.5-76. Laboratories; reporting requirements |
| Section 410IAC1-2.5-77. Disease intervention measures; responsibility to investigate and implement |
| Section 410IAC1-2.5-78. Confidentiality of medical and epidemiological information |
| Section 410IAC1-2.5-79. General control measures |
| Section 410IAC1-2.5-80. Animal bites; specific control measures |
| Section 410IAC1-2.5-81. Anthrax; specific control measures |
| Section 410IAC1-2.5-82. Arboviral disease (non-neuroinvasive and neuroinvasive); specific control measures |
| Section 410IAC1-2.5-83. Babesiosis; specific control measures |
| Section 410IAC1-2.5-84. Botulism; specific control measures |
| Section 410IAC1-2.5-85. Brucellosis; specific control measures |
| Section 410IAC1-2.5-86. Campylobacteriosis; specific control measures |
| Section 410IAC1-2.5-87. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE); specific control measures |
| Section 410IAC1-2.5-88. Chancroid; specific control measures |
| Section 410IAC1-2.5-89. Chlamydial infections, genital; specific control measures |
| Section 410IAC1-2.5-90. Cholera; specific control measures |
| Section 410IAC1-2.5-91. Coccidioidomycosis; specific control measures |
| Section 410IAC1-2.5-92. Cryptosporidiosis; specific control measures |
| Section 410IAC1-2.5-93. Cyclosporiasis; specific control measures |
| Section 410IAC1-2.5-94. Cysticercosis; specific control measures |
| Section 410IAC1-2.5-95. Diphtheria; specific control measures |
| Section 410IAC1-2.5-96. Ehrlichiosis; specific control measures |
| Section 410IAC1-2.5-98. Giardiasis; specific control measures |
| Section 410IAC1-2.5-99. Gonorrhea; specific control measures |
| Section 410IAC1-2.5-100. Granuloma inguinale; specific control measures |
| Section 410IAC1-2.5-101. Haemophilus influenzae invasive disease; specific control measures |
| Section 410IAC1-2.5-102. Hansen's disease; specific control measures |
| Section 410IAC1-2.5-103. Hantavirus; specific control measures |
| Section 410IAC1-2.5-104. Hepatitis, viral, type A; specific control measures |
| Section 410IAC1-2.5-105. Hepatitis, viral, type B and type D; specific control measures |
| Section 410IAC1-2.5-106. Hepatitis C infection; specific control measures |
| Section 410IAC1-2.5-107. Hepatitis E infection; specific control measures |
| Section 410IAC1-2.5-108. Histoplasma capsulatum; specific control measures |
| Section 410IAC1-2.5-109. Human immunodeficiency virus infection/disease; specific control measures |
| Section 410IAC1-2.5-110. Influenza-associated death; specific control measures |
| Section 410IAC1-2.5-111. Latent tuberculosis infection; specific control measures |
| Section 410IAC1-2.5-112. Legionellosis; specific control measures |
| Section 410IAC1-2.5-113. Leptospirosis; specific control measures |
| Section 410IAC1-2.5-114. Listeriosis; specific control measures |
| Section 410IAC1-2.5-115. Lyme disease; specific control measures |
| Section 410IAC1-2.5-116. Lymphogranuloma venereum; specific control measures |
| Section 410IAC1-2.5-117. Malaria; specific control measures |
| Section 410IAC1-2.5-118. Measles (rubeola); specific control measures |
| Section 410IAC1-2.5-119. Meningococcal invasive disease; specific control measures |
| Section 410IAC1-2.5-120. Mumps; specific control measures |
| Section 410IAC1-2.5-121. Novel influenza A; specific control measures |
| Section 410IAC1-2.5-122. Pertussis; specific control measures |
| Section 410IAC1-2.5-123. Plague; specific control measures |
| Section 410IAC1-2.5-124. Poliomyelitis; specific control measures |
| Section 410IAC1-2.5-125. Psittacosis; specific control measures |
| Section 410IAC1-2.5-126. Q fever; specific control measures |
| Section 410IAC1-2.5-127. Rabies, human and animal; specific control measures |
| Section 410IAC1-2.5-128. Rocky Mountain spotted fever; specific control measures |
| Section 410IAC1-2.5-129. Rubella (German measles); specific control measures |
| Section 410IAC1-2.5-130. Salmonellosis, nontyphoidal; specific control measures |
| Section 410IAC1-2.5-131. Shigellosis; specific control measures |
| Section 410IAC1-2.5-132. Smallpox; specific control measures |
| Section 410IAC1-2.5-133. Staphylococcus aureus, vancomycin resistant level = 8 µg/mL, or severe Staphylococcus aureus in a previously healthy person; specific control measures |
| Section 410IAC1-2.5-134. Streptococcus pneumoniae, invasive disease; specific control measures |
| Section 410IAC1-2.5-135. Streptococcal invasive disease, group A and streptococcal toxic shock syndrome; specific control measures |
| Section 410IAC1-2.5-136. Syphilis; specific control measures |
| Section 410IAC1-2.5-137. Taeniasis; specific control measures |
| Section 410IAC1-2.5-138. Tetanus; specific control measures |
| Section 410IAC1-2.5-139. Toxic shock syndrome; specific control measures |
| Section 410IAC1-2.5-140. Trichinosis; specific control measures |
| Section 410IAC1-2.5-141. Tuberculosis; specific control measures |
| Section 410IAC1-2.5-142. Tularemia; specific control measures |
| Section 410IAC1-2.5-143. Typhoid and paratyphoid fever; specific control measures |
| Section 410IAC1-2.5-144. Typhus, endemic (fleaborne); specific control measures |
| Section 410IAC1-2.5-145. Varicella (chickenpox); specific control measures |
| Section 410IAC1-2.5-146. Vibriosis; specific control measures |
| Section 410IAC1-2.5-147. Yellow fever; specific control measures |
| Section 410IAC1-2.5-148. Yersiniosis; specific control measures |
| Section 410IAC1-2.5-149. Incorporation by reference |